Suspension 100 Odin Pharmaceuticals

£70.00

Suspension 100 Odin Pharmaceuticals is a testosterone suspension research compound available for in-vitro laboratory investigations. Laboratory-grade formulation suitable for molecular and biochemical studies requiring immediate-release testosterone preparations for controlled research protocols.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Suspension 100 Odin Pharmaceuticals
Suspension 100 Odin Pharmaceuticals
£70.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Suspension 100 Odin Pharmaceuticals at a Glance

Suspension 100 Odin Pharmaceuticals is a testosterone suspension research chemical formulated for laboratory investigations requiring immediate bioavailability characteristics. This aqueous-based compound represents one of the fastest-acting testosterone preparations available for Stroid UK Shop, providing researchers with an unesterified testosterone molecule suspended in solution. The formulation eliminates esterification delays, making it particularly valuable for studies examining rapid hormonal response mechanisms and acute testosterone effects in controlled laboratory environments.

Unlike esterified testosterone compounds found in our specialised research category, this suspension maintains the hormone in its pure, unmodified state. The aqueous suspension medium allows for immediate dissolution upon administration in research models, providing investigators with precise temporal control over testosterone exposure in experimental protocols. This characteristic proves essential for time-sensitive research applications where delayed release would compromise experimental validity.

Laboratory Applications

Research investigators utilise testosterone suspension for studies examining immediate androgenic and anabolic pathway activation in cellular and tissue models. The compound’s rapid bioavailability makes it suitable for investigations into acute testosterone effects on gene expression, protein synthesis pathways, and receptor binding kinetics. Studies examining testosterone’s role in muscle protein synthesis, bone mineralisation processes, and neurological function benefit from the immediate-acting characteristics of this suspension formulation.

Comparative endocrinology research employs this compound alongside other testosterone preparations to evaluate release kinetics and biological response timelines. The suspension serves as a reference standard for studies comparing testosterone delivery methods and their respective pharmacokinetic profiles. Research into testosterone’s effects on metabolic pathways, similar to investigations conducted with compounds from our selective androgen receptor modulator collection and peptide research range, benefits from the predictable onset characteristics of this formulation.

Technical Specifications

Suspension 100 Odin Pharmaceuticals Research Specifications
Parameter Specification
Active Compound Testosterone (unesterified)
Concentration 100mg/mL
Formulation Aqueous suspension
Manufacturer Odin Pharmaceuticals
Molecular Formula C₁₉H₂₈O₂
Molecular Weight 288.42 g/mol
CAS Number 58-22-0
Storage Requirements Room temperature, protect from light

Research Compliance Statement

Suspension 100 Odin Pharmaceuticals is manufactured exclusively for in-vitro research applications and laboratory investigations. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper handling protocols, adequate ventilation, and appropriate safety measures when conducting studies with this testosterone suspension. All investigations should comply with institutional research guidelines and applicable regulations governing research chemical use. Storage should maintain compound stability while preventing unauthorised access or accidental exposure.

Related